Skip to main content

Animations

MJFF Publications

7631 - 7640 of 9039 Results
Title
Year
  • Year
  • 2018
  • 2020
  • 2012
  • 2020
  • 2022
  • 2022
  • 2021
  • 2022
  • 2020
  • 2022
  • Summary Details
    OPEN
    Title: The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.12591
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12921
    Citation Count: 338
  • Summary Details
    OPEN
    Title: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9a
    Citation Count: 155
  • Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    2020
    Summary Details
    RESTRICTED
    Title: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418
    Citation Count: 1
  • Summary Details
    OPEN
    Title: ggtranscript : an R package for the visualization and interpretation of transcript isoforms using ggplot2
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btac409
    Citation Count: 726
  • Summary Details
    OPEN
    Title: The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddac233
    Citation Count: 13
  • Summary Details
    OPEN
    Title: The effects of mood and cognition on daily functioning and quality of life in older people living with HIV and people with Parkinson’s disease.
    Journal Name: Neuropsychology
    Publisher: American Psychological Association (APA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1037/neu0000760
    Citation Count: 3
  • Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.
    2022
    Summary Details
    RESTRICTED
    Title: Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.
    Journal Name: Neuropsychology
    Publisher: American Psychological Association (APA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1037/neu0000795
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation
    Journal Name: Mucosal Immunology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41385-020-00354-7
    Citation Count: 40
  • Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
    2022
    Summary Details
    OPEN
    Title: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605
    Citation Count: 24
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.